Low MOQ for Neratinib - Semaglutide for Type 2 Diabetes – Gentolex

Short Description:

Send email to us

Product Detail

Product Tags

Feedback (2)

Our products and solutions are greatly recognized and trustworthy by customers and may fulfill constantly changing financial and social requires for Dibenzosuberone, Dipotassium Tetrachloroplatinate10025-99-7, Escitalopram Oxalate, Our tenet is "Reasonable prices, economical production time and very best service" We hope to cooperate with much more shoppers for mutual enhancement and benefits.

Low MOQ for Neratinib - Semaglutide for Type 2 Diabetes – Gentolex Detail:

Product Detail

Name	Semaglutide
CAS number	910463-68-2
Molecular formula	C187H291N45O59
Molecular weight	4113.57754
EINECS Number	203-405-2

Synonyms

Sermaglutide; Semaglutide fandachem; Semaglutide impurity; Sermaglutide USP/EP; semaglutide; Sermaglutide CAS 910463 68 2; Ozempic,

Description

Semaglutide is a new generation of GLP-1 (glucagon-like peptide-1) analogs, and semaglutide is a long-acting dosage form developed based on the basic structure of liraglutide, which has a better effect in the treatment of type 2 diabetes. Novo Nordisk has completed 6 Phase IIIa studies of semaglutide injection, and submitted a new drug registration application for semaglutide weekly injection to the U.S. Food and Drug Administration (FDA) on December 5, 2016. A Marketing Authorization Application (MAA) was also submitted to the European Medicines Agency (EMA).

Compared with liraglutide, semaglutide has a longer aliphatic chain and increased hydrophobicity, but semaglutide is modified with a short chain of PEG, and its hydrophilicity is greatly enhanced. After PEG modification, it can not only bind closely to albumin, cover the enzymatic hydrolysis site of DPP-4, but also reduce renal excretion, prolong the biological half-life, and achieve the effect of long circulation.

Application

Semaglutide is a long-acting dosage form developed based on the basic structure of liraglutide, which is more effective in treating type 2 diabetes.

Bioactivity

Semaglutide (Rybelsus, Ozempic, NN9535, OG217SC, NNC0113-0217) is a long-acting glucagon-like peptide 1 (GLP-1) analog, an agonist of GLP-1receptor, with a potential type 2 Therapeutic efficacy of diabetes mellitus (T2DM).

Quality System

In general, quality system and assurance is in place covering all stage of production of the finished product. Adequate manufacturing and control operations are performed in compliance with the approved procedures/ specifications. Change control and Deviation handling system is in place, and necessary impact assessment and investigation were conducted. Proper procedures are in place to ensure quality of product prior to release into the market.

Product detail pictures:

Related Product Guide:

As a result of ours specialty and service consciousness, our company has won a good reputation among customers all over the world for Low MOQ for Neratinib - Semaglutide for Type 2 Diabetes – Gentolex , The product will supply to all over the world, such as: Lisbon, Washington, Puerto Rico, We have sufficient experience in producing products according to samples or drawings. We warmly welcome customers from home and abroad to visit our company, and to cooperate with us for a splendid future together.

1-Carbethoxy-4-Piperidone

2,6-Diaminopyridine

Alpha Helix Amino Acids

Amino Acids And Peptides

Chloride High Meaning

Naturally Occurring Amino Acids

As an international trading company, we have numerous partners, but about your company, I just want to say, you are really good, wide range, good quality, reasonable prices, warm and thoughtful service, advanced technology and equipment and workers have professional training, feedback and product update is timely, in short, this is a very pleasant cooperation, and we look forward to the next cooperation!